<DOC>
	<DOCNO>NCT02182596</DOCNO>
	<brief_summary>For several year , effective standard induction chemotherapy AML limit association anthracycline aracytine . GO first effective target antibody use leukemia patient . In previous study , show efficacy safety fractionate dos GO use single agent treatment adult AML patient first relapse . In present study possibility combine fractionated dos GO escalate dose 3+7 regimen old study relapsed AML patient &gt; 50 &lt; 70 year .</brief_summary>
	<brief_title>DNR AraC Combined Fractionated Mylotarg® Patients With First Relapse AML</brief_title>
	<detailed_description>Induction course : GO 3mg/m2 day 1 , 4,7 + three dose level follow : level 1 : DNR : 45 mg/m2 x 3 day + AraC : 100 mg/m2 x 7 day level 2 : DNR : 60 mg/m2 x 3 day + AraC : 100 mg/m2 x 7 day level 3 : DNR 60 mg/m2 x 3 day + AraC : 200 mg/m2 x 7 day . 20 mg methylprednisolone prior GO infusion . Consolidation course : patient CR may receive 2 additional course consolidation chemotherapy Amsacrine 90 mg/m2 daily 3 day , Ara-C ( 1g/m2/12 hour x 3 day ) + GO 3 mg/m2 day 1 . Treatment HSCT offer discretion physician charge patient . A delay last infusion GO HSCT 3 month recommend</detailed_description>
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Leukemia , Myeloid</mesh_term>
	<mesh_term>Leukemia , Myeloid , Acute</mesh_term>
	<mesh_term>Cytarabine</mesh_term>
	<mesh_term>Gemtuzumab</mesh_term>
	<criteria>Patients morphologically proven diagnosis CD33positive AML : 1 . Age ≥ 50 year ≤ 70 year . 2 . First relapse AML duration first CR ≥ 3 ≤18 month 3 . ECOG performance status 0 3 4 . Negative serology HIV , HBV HBC ( except post vaccination ) 5 . Serum creatinine ≤ 2N ; AST ALT ≤ 2N ; total bilirubin ≤ 2N 6 . Cardiac function determine radionuclide echography within normal limit . 7 . Negative serum pregnancy test within one week treatment woman child bear potential 8 . Signed informed consent . 1 . M3AML 2 . AML follow diagnose myelodysplastic syndrome myeloproliferation 3 . Known central nervous system involvement AML 4 . Prior treatment HSCT . 5 . Previous treatment Anti CD33 antibodies 6 . Uncontrolled infection 7 . Other active malignancy</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>Acute Myeloid Leukemia</keyword>
	<keyword>First relapse AML</keyword>
</DOC>